Related Experiment Video
Updated: Sep 23, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53
Takashi Kimura1, Mitsukazu Gotoh, Yusuke Nakamura
1Human Genome Center, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Abstract:
To identify p53-target genes we have been using a cDNA-microarray system to assess gene expression in a p53-mutated glioblastoma cell line (U373MG) after adenovirus-mediated transfer of wild-type p53 into the p53-deficient cells. In the work reported here, expression of hCDC4b, which encodes one of the four subunits of the SCF (ubiquitin ligase) complex responsible for degradation of cyclin E, was dramatically up-regulated by infection with Ad-p53. An electrophoretic mobility-shift assay and a chromatin immunoprecipitation assay indicated that a potential p53-binding site (p53BS) present in exon 1b of the hCDC4 gene was able to bind to p53, and a reporter assay confirmed that this p53BS had p53-dependent transcriptional activity. Expression of endogenous hCDC4b, but not the alternative transcript of this gene, hCDC4a, was induced in a p53-dependent manner in response to genotoxic stresses caused by UV irradiation and adriamycin treatment, suggesting that each transcript has a different functional role. These results suggest that hCDC4b is a previously unrecognized transcriptional target of the p53 protein, and that by negatively regulating cyclin E through induction of hCDC4b, p53 might stop cell-cycle progression at G0-G1. This would represent a novel mechanism for p53-dependent control of the cell cycle, in addition to the well-known p21(WAF1) machinery.
Insights
The tumor suppressor p53 directly regulates hCDC4b gene expression, a novel finding that may explain p53
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 protein is a critical tumor suppressor involved in cell cycle regulation and DNA repair.
- Glioblastoma is an aggressive brain tumor with a high mutation rate in the p53 pathway.
- Understanding p53-target genes is crucial for developing effective cancer therapies.
Purpose of the Study:
- To identify novel p53-target genes using a cDNA-microarray system.
- To investigate the role of hCDC4b in p53-mediated cell cycle arrest.
Main Methods:
- Adenovirus-mediated transfer of wild-type p53 into p53-deficient glioblastoma cells (U373MG).
- cDNA-microarray analysis to assess gene expression changes.
- Electrophoretic mobility-shift assay (EMSA) and chromatin immunoprecipitation (ChIP) to confirm p53 binding.
- Reporter assays to determine transcriptional activity.
- Genotoxic stress induction using UV irradiation and adriamycin.
Main Results:
- Expression of hCDC4b, a subunit of the SCF ubiquitin ligase complex, was significantly upregulated by wild-type p53.
- A functional p53-binding site (p53BS) was identified in exon 1b of the hCDC4 gene, demonstrating p53-dependent transcriptional activity.
- Endogenous hCDC4b expression was induced in a p53-dependent manner upon genotoxic stress, unlike the alternative hCDC4a transcript.
- p53 negatively regulates cyclin E degradation via hCDC4b induction.
Conclusions:
- hCDC4b is a novel transcriptional target of the p53 protein.
- p53-induced hCDC4b may contribute to cell cycle arrest at the G0-G1 phase by downregulating cyclin E.
- This represents a new mechanism of p53-dependent cell cycle control, complementing the known p21(WAF1) pathway.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
Abnormal Proliferation

